Showing results (191-200 of 1,648) with videos related to
Sort By:
Pageof 165
Hepatology International|July 16, 2021
Longitudinal progression of clinical variables associated with graded liver injury in COVID-19 patientsJustin Y Lu, Harnadar Anand, Shalom Z Frager, et al.Hepatology International|July 18, 2021
Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failureNipun Verma, Radha Krishan Dhiman, Ashok Choudhury, et al.Hepatology International|July 16, 2013
Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosisAlessandra Dellavance, Eduardo Luiz R Cançado, Clarice Pires Abrantes-Lemos, et al.Hepatology International|April 13, 2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year resultsXieer Liang, Zhiliang Gao, Qing Xie, et al.Hepatology International|June 24, 2017
Current progress in host innate and adaptive immunity against hepatitis C virus infectionJijing Shi, Yuanyuan Li, Wenxian Chang, et al.Hepatology International|May 28, 2017
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the eggJuan P Arab, Rosa M Martin-Mateos, Vijay H ShahHepatology International|April 12, 2018
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Qing Xie, Jin Lin Hou, et al.Hepatology International|May 10, 2018
Immune checkpoint receptors: homeostatic regulators of immunityAntonio Riva, Shilpa ChokshiHepatology International|December 13, 2018
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri LankaMadunil Anuk Niriella, A Kasturiratne, A Pathmeswaran, et al.Hepatology International|December 13, 2018
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?Tatsuo Kanda, George K K Lau, Lai Wei, et al.Pageof 165